Illumina GmbH acts as the German distribution entity for medical technology devices from the Illumina Group, specializing in the analysis of genetic variations and functions. The product portfolio includes sequencing platforms, array systems, and associated consumables as well as services such as installation and maintenance. Customers include scientific institutions, hospitals, laboratories, and companies in the biotechnology and molecular diagnostics sectors. As a limited-risk distributor, the company is an integral part of the global Illumina Group and also holds shares in subsidiaries in France, Italy, and Switzerland.
Vermarktung von Laborinstrumenten und Reagenzgläsern für die Analyse von genetischen Veränderungen und Funktionen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 225955 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Norbert Keller | Geschäftsführer(in) | Eindhoven/ Niederlande |
| Nicholas Sales | Geschäftsführer(in) | Linton / Vereinigtes Königreich |
| Markus Voßmann | Geschäftsführer(in) | Berlin |
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 225955 (as of 2 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 11.02.2021 | Company Name Registered | Illumina GmbH |
| 11.02.2021 | Registered Seat | Berlin |
| 11.02.2021 | Business Address Registered | Eichhornstraße 3, 10785 Berlin |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 11.02.2021 | Share Capital Set | — | 25.000 € |
| Date | Contract | Value |
|---|---|---|
| 2.11.2026 | Supplier · Universitätsklinikum Halle (Saale) AöR | 376.729 € |
| 29.10.2026 | Supplier · Charité - Universitätsmedizin Berlin | — |
| 20.10.2026 | Genomsequenziergerät Supplier · Bundesinstitut für Risikobewertung (BfR) | — |
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 225955 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €264,379,885 | €6,804,884 | €64,881,711 | — |
| 2024 | €242,051,688 | €11,317,656 | €82,361,792 | — |
| 2023 | €237,842,549 | €6,332,074 | €56,077,529 | — |
| 2022 | €233,837,557 | €7,924,665 | €79,661,155 | — |
| 2021 | €204,323,924 | €29,346,882 | €67,293,769 | — |
| 2020 | €159,523,864 | €2,617,373 | €68,137,367 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 225955 (as of 2 November 2026)
Hermès Germany GmbH
München · Einzelhandel mit Waren verschiedener Art, Hauptrichtung Nicht-Nahrungsmittel
Intertec Beteiligungs-GmbH
Rülzheim · Großhandel mit Fertigwaren, ohne ausgeprägten Schwerpunkt
Herbrand GmbH
Kevelaer · Einzelhandel mit Kraftwagen mit einem zulässigen Gesamtgewicht von 3,5 t oder weniger
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €21,071,593 | 8.5% |
| Material Costs | €226,534,730 | 91.5% |
| Interest & Similar | €281 | 0.0% |
